Incidence and burden of long COVID in Africa: a systematic review and meta-analysis

[1]  M. Hassan,et al.  Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination , 2023, European Archives of Psychiatry and Clinical Neuroscience.

[2]  E. Topol,et al.  Long COVID: major findings, mechanisms and recommendations , 2023, Nature Reviews Microbiology.

[3]  O. Bruyère,et al.  Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients , 2022, Internal and Emergency Medicine.

[4]  L. Merson,et al.  A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants , 2022, International Journal of Infectious Diseases.

[5]  O. Bruyère,et al.  Interventions for Improving Long COVID-19 Symptomatology: A Systematic Review , 2022, Viruses.

[6]  L. Merson,et al.  Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study , 2022, The Lancet Global Health.

[7]  Jue Liu,et al.  Long-Term Consequences of COVID-19 at 6 Months and Above: A Systematic Review and Meta-Analysis , 2022, International journal of environmental research and public health.

[8]  C. Caminiti,et al.  Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis , 2022, Journal of clinical medicine.

[9]  Oscar J. Pellicer-Valero,et al.  Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study , 2022, Journal of clinical medicine.

[10]  Nelson B Rodrigues,et al.  Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis , 2021, Brain, Behavior, and Immunity.

[11]  F. Bai,et al.  Female gender is associated with long COVID syndrome: a prospective cohort study , 2021, Clinical Microbiology and Infection.

[12]  S. Stewart,et al.  Long COVID risk - a signal to address sex hormones and women's health , 2021, The Lancet Regional Health - Europe.

[13]  David A. Drew,et al.  Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study , 2021, The Lancet Infectious Diseases.

[14]  H. Ashrafian,et al.  Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis , 2021, EClinicalMedicine.

[15]  F. Catalá-López,et al.  How to properly use the PRISMA Statement , 2021, Systematic Reviews.

[16]  B. Ibrahim,et al.  Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis , 2020, Intervirology.

[17]  P. Soysal,et al.  Assessing the quality of studies in meta‐research: Review/guidelines on the most important quality assessment tools , 2020, Pharmaceutical statistics.

[18]  S. Nahavandi,et al.  Risk factors prediction, clinical outcomes, and mortality in COVID‐19 patients , 2020, medRxiv.

[19]  Mike Clarke,et al.  A minimal common outcome measure set for COVID-19 clinical research , 2020, The Lancet Infectious Diseases.

[20]  Claudio Luchini,et al.  Assessing the quality of studies in meta-analyses: Advantages and limitations of the Newcastle Ottawa Scale , 2017 .

[21]  S. Murthy,et al.  Intensive Care Unit Capacity in Low-Income Countries: A Systematic Review , 2015, PloS one.

[22]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[23]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[24]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.